These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effect of rofecoxib on prednisolone and prednisone pharmacokinetics in healthy subjects. Schwartz JI; Mukhopadhyay S; Porras AG; Viswanathan-Aiyer KJ; Adcock S; Ebel DL; Gertz BJ J Clin Pharmacol; 2003 Feb; 43(2):187-92. PubMed ID: 12616672 [TBL] [Abstract][Full Text] [Related]
28. The non-linear pharmacokinetics of prednisone and prednisolone. III. Experiments using the rabbit as an animal model. Ferry JJ; Wagner JG Biopharm Drug Dispos; 1988; 9(4):363-76. PubMed ID: 3207856 [TBL] [Abstract][Full Text] [Related]
29. Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats. Huang ML; Jusko WJ J Pharmacokinet Biopharm; 1990 Oct; 18(5):401-21. PubMed ID: 2266496 [TBL] [Abstract][Full Text] [Related]
31. Bioavailability and reversible metabolism of prednisone and prednisolone in man. Garg V; Jusko WJ Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967 [TBL] [Abstract][Full Text] [Related]
32. [Glucocorticoids: mode of action and pharmacokinetics]. Emilie D; Etienne S Rev Prat; 1990 Feb; 40(6):511-7. PubMed ID: 2320875 [TBL] [Abstract][Full Text] [Related]
33. Prednisolone and Prednisone Pharmacokinetics in Pediatric Renal Transplant Recipients-A Prospective Study. Skauby RH; Bjerre A; Sæves I; Vethe NT; Bremer S; Svarstad A; Bergan S Ther Drug Monit; 2017 Oct; 39(5):472-482. PubMed ID: 28749817 [TBL] [Abstract][Full Text] [Related]
34. Effect of the anti-inflammatory agent tenidap on the pharmacokinetics and pharmacodynamics of prednisolone. Garg V; Blum R; Wilner KD; Jusko WJ J Clin Pharmacol; 1992 Mar; 32(3):222-30. PubMed ID: 1564126 [TBL] [Abstract][Full Text] [Related]
35. A practical limited sampling strategy to predict free prednisolone exposure and glycemia in kidney transplant recipients. Yates CJ; Barraclough KA; McWhinney BC; Ungerer JP; Fullinfaw RO; Colman PG; Fourlanos S; Cohney SJ Ther Drug Monit; 2014 Feb; 36(1):18-23. PubMed ID: 24335760 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetic parameters of prednisone and prednisolone in healthy volunteers]. Etienne SD; Vandermeersch V; Chosidow O; Vu-Thi-My-Le C; Godeau P; Diquet B; Herson S Ann Med Interne (Paris); 1990; 141(6):507-11. PubMed ID: 2285202 [TBL] [Abstract][Full Text] [Related]
37. Prednisolone: limited sampling strategies for estimating pharmacokinetic parameters. Suarez-Kurtz G; Estrela Rde C; Salvadori MC Ther Drug Monit; 2004 Feb; 26(1):16-22. PubMed ID: 14749544 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of prednisone and prednisolone in a case of hypothyroidism: effect of replacement therapy. Bergamaschi S; Rusconi R; Gervasoni M; Rigamonti AE; Cella S; Bareggi SR Steroids; 2005 Oct; 70(11):787-9. PubMed ID: 16045952 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients. Chosidow O; Etienne SD; Diquet B; Vandermeersch V; Vu-Thi-My-Le C; Herson S; Puech AJ Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):376-80. PubMed ID: 1938000 [TBL] [Abstract][Full Text] [Related]
40. Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP. Baudry E; Huguet S; Couderc AL; Chaibi P; Bret F; Verny C; Weill S; Madar O; Urien S; Rezai K Cancer Chemother Pharmacol; 2019 Apr; 83(4):775-785. PubMed ID: 30689002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]